Diagnostics against antimicrobial resistance – the next big move
Chances are, you were prescribed antibiotics at least once in the last year or two. But were they really necessary? The Centers for Disease Control and Prevention (CDC) estimates that about 47 million antibiotic courses each year are prescribed unnecessarily, which is about 30% of all antibiotics prescribed.1
Although antibiotics may be the most recognisable antimicrobial to the public, there are others that fall under this category and are at risk of no longer being effective treatments. ‘Antimicrobial’ is an umbrella term for medicines such as antibiotics, antifungals, antivirals and antiparasitics that prevent and treat infections in humans, as well as animals and plants. Antimicrobial resistance (AMR) occurs when microorganisms evolve and no longer respond to conventional antimicrobial treatments, making infections harder and harder to treat – in some cases leaving no treatment options available.2
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.